# Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates

> **NCT06894446** · PHASE3 · WITHDRAWN · sponsor: **Baxter Healthcare Corporation**

## Conditions studied

- Malnutrition, Infant
- Enteral Feeding Intolerance

## Interventions

- **DIETARY_SUPPLEMENT:** Numeta G13%E
- **DIETARY_SUPPLEMENT:** Compounded Parenteral Nutrition (cPN) solution

## Key facts

- **NCT ID:** NCT06894446
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-08-20
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business decision due to practice in China
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894446, "Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06894446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*